135 related articles for article (PubMed ID: 38362804)
1. Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy.
van den Berg E; Kersten I; Brinkmalm G; Johansson K; de Kort AM; Klijn CJM; Schreuder FHBM; Gobom J; Stoops E; Portelius E; Gkanatsiou E; Zetterberg H; Blennow K; Kuiperij HB; Verbeek MM
J Neurochem; 2024 Feb; ():. PubMed ID: 38362804
[TBL] [Abstract][Full Text] [Related]
2. Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
De Kort AM; Kuiperij HB; Marques TM; Jäkel L; van den Berg E; Kersten I; van Berckel-Smit HEP; Duering M; Stoops E; Abdo WF; Rasing I; Voigt S; Koemans EA; Kaushik K; Warren AD; Greenberg SM; Brinkmalm G; Terwindt GM; Wermer MJH; Schreuder FHBM; Klijn CJM; Verbeek MM
Ann Neurol; 2023 Jun; 93(6):1173-1186. PubMed ID: 36707720
[TBL] [Abstract][Full Text] [Related]
3. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid Biomarkers and Amyloid-β Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation.
Sakai K; Noguchi-Shinohara M; Tanaka H; Ikeda T; Hamaguchi T; Kakita A; Yamada M; Ono K
J Alzheimers Dis; 2023; 91(3):1173-1183. PubMed ID: 36565118
[TBL] [Abstract][Full Text] [Related]
5. Intracisternal injection of beta-amyloid seeds promotes cerebral amyloid angiopathy.
Yuan Q; Xian YF; Huang YF; Wu W; Song YQ; Lin ZX
Brain Behav Immun; 2020 Oct; 89():628-640. PubMed ID: 32739364
[TBL] [Abstract][Full Text] [Related]
6. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
[TBL] [Abstract][Full Text] [Related]
7. Origins of Beta Amyloid Differ Between Vascular Amyloid Deposition and Parenchymal Amyloid Plaques in the Spinal Cord of a Mouse Model of Alzheimer's Disease.
Yuan Q; Liu X; Xian YF; Tang Y; Zou J; Zhang X; Huang P; Wu W; Song YQ; Lin ZX
Mol Neurobiol; 2020 Jan; 57(1):278-289. PubMed ID: 31325023
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
van den Berg E; Nilsson J; Kersten I; Brinkmalm G; de Kort AM; Klijn CJM; Schreuder FHBM; Jäkel L; Gobom J; Portelius E; Zetterberg H; Brinkmalm A; Blennow K; Kuiperij HB; Verbeek MM
J Alzheimers Dis; 2023; 92(2):467-475. PubMed ID: 36776062
[TBL] [Abstract][Full Text] [Related]
9. MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy.
Marazuela P; Solé M; Bonaterra-Pastra A; Pizarro J; Camacho J; Martínez-Sáez E; Kuiperij HB; Verbeek MM; de Kort AM; Schreuder FHBM; Klijn CJM; Castillo-Ribelles L; Pancorbo O; Rodríguez-Luna D; Pujadas F; Delgado P; Hernández-Guillamon M
Acta Neuropathol Commun; 2021 Sep; 9(1):154. PubMed ID: 34530925
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Aβ42, and Aβ40 in Probable Cerebral Amyloid Angiopathy.
Grangeon L; Paquet C; Guey S; Zarea A; Martinaud O; Rotharmel M; Maltête D; Quillard-Muraine M; Nicolas G; Charbonnier C; Chabriat H; Wallon D
J Alzheimers Dis; 2022; 87(2):791-802. PubMed ID: 35367960
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy: New Data and Quantitative Meta-Analysis.
Margraf NG; Jensen-Kondering U; Weiler C; Leypoldt F; Maetzler W; Philippen S; Bartsch T; Flüh C; Röcken C; Möller B; Royl G; Neumann A; Brüggemann N; Roeben B; Schulte C; Bender B; Berg D; Kuhlenbäumer G
Front Aging Neurosci; 2022; 14():783996. PubMed ID: 35237145
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling in cerebral amyloid angiopathy reveals an overlap with CADASIL highlighting accumulation of HTRA1 and its substrates.
Zellner A; Müller SA; Lindner B; Beaufort N; Rozemuller AJM; Arzberger T; Gassen NC; Lichtenthaler SF; Kuster B; Haffner C; Dichgans M
Acta Neuropathol Commun; 2022 Jan; 10(1):6. PubMed ID: 35074002
[TBL] [Abstract][Full Text] [Related]
14. Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy.
de Kort AM; Kuiperij HB; Jäkel L; Kersten I; Rasing I; van Etten ES; van Rooden S; van Osch MJP; Wermer MJH; Terwindt GM; Schreuder FHBM; Klijn CJM; Verbeek MM
Alzheimers Res Ther; 2023 Jun; 15(1):102. PubMed ID: 37270536
[TBL] [Abstract][Full Text] [Related]
15. Early Aβ reduction prevents progression of cerebral amyloid angiopathy.
Schelle J; Wegenast-Braun BM; Fritschi SK; Kaeser SA; Jährling N; Eicke D; Skodras A; Beschorner N; Obermueller U; Häsler LM; Wolfer DP; Mueggler T; Shimshek DR; Neumann U; Dodt HU; Staufenbiel M; Jucker M
Ann Neurol; 2019 Oct; 86(4):561-571. PubMed ID: 31359452
[TBL] [Abstract][Full Text] [Related]
16. Screening for cerebral amyloid angiopathy based on serological biomarkers analysis using a dielectrophoretic force-driven biosensor platform.
Kim HJ; Park D; Yun G; Kim H; Kim HG; Lee KM; Hong IK; Park KC; Lee JS; Hwang KS
Lab Chip; 2021 Nov; 21(23):4557-4565. PubMed ID: 34724019
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Wacongne A; Ayrignac X; Charif M; Fourcade G; Azakri S; Le Floch A; Bouly S; Marelli C; Arquizan C; Hirtz C; Gabelle A; Thouvenot E; Lehmann S
J Alzheimers Dis; 2016; 50(3):759-764. PubMed ID: 26757185
[TBL] [Abstract][Full Text] [Related]
18. Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis.
Charidimou A; Friedrich JO; Greenberg SM; Viswanathan A
Neurology; 2018 Feb; 90(9):e754-e762. PubMed ID: 29386280
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Collombier L; Demattei C; Wacongne A; Charif M; Ayrignac X; Azakri S; Gaillard N; Boudousq V; Lehmann S; Menjot de Champfleur N; Thouvenot E
J Alzheimers Dis; 2018; 61(3):1107-1117. PubMed ID: 29254099
[TBL] [Abstract][Full Text] [Related]
20. Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
Costa AS; Pinho J; Kučikienė D; Reich A; Schulz JB; Reetz K
J Alzheimers Dis; 2021; 79(4):1661-1672. PubMed ID: 33492291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
